OPDP

OPDP warns AcelRx over Dsuvia promotional materials
OPDP warns AcelRx over Dsuvia promotional materials
RAPS.org
FDA
OPDP
Dsuvia
AcelRx
warning letter
opioids
Flag link:
FDA to Study Instagram and Social Media Influencers
FDA to Study Instagram and Social Media Influencers
BioSpace
FDA
OPDP
social media
social media influencers
Instagram
Flag link:
Too Much, Too Soon: OPDP Issues Untitled Letter for Pre-approval Promotion
Too Much, Too Soon: OPDP Issues Untitled Letter for Pre-approval Promotion
FDA Law Blog
OPDP
drug marketing
pre-approval promotion
Flag link:
FDA’s OPDP Warns Insomnia Drugmaker Over Email
FDA’s OPDP Warns Insomnia Drugmaker Over Email
RAPS.org
FDA
OPDP
Galt Pharmaceuticals
Doral
Flag link:
Do People Understand Cancer Drug Ads on TV? Drugmakers Weigh in on FDA Research
Do People Understand Cancer Drug Ads on TV? Drugmakers Weigh in on FDA Research
RAPS.org
FDA
cancer
consumers
DTC ads
television ads
OPDP
Flag link:
Pharma ad police issues 2019's first warning over promotion of unapproved imaging drug
Pharma ad police issues 2019's first warning over promotion of unapproved imaging drug
Fierce Pharma
FDA
warning letters
OPDP
Phoenix Molecular Imaging
Flag link:
FDA’s OPDP Warns MannKind for Facebook Post
FDA’s OPDP Warns MannKind for Facebook Post
RAPS.org
Afrezza
warning letter
FDA
OPDP
Facebook
social media
diabetes
MannKind
Flag link:
FDA calls Pfizer Estring marketing misleading
FDA calls Pfizer Estring marketing misleading
Biopharma Dive
FDA
OPDP
Pfizer
Estring
drug ads
DTC ads
Flag link:
FDA's promo police put pharma marketing to the test with 6 new research studies
FDA's promo police put pharma marketing to the test with 6 new research studies
Fierce Pharma
FDA
OPDP
drug marketing
drug ads
Flag link:
Marketing police send 2018's first enforcement letter to Collegium over misleading opioid exhibit booth
Marketing police send 2018's first enforcement letter to Collegium over misleading opioid exhibit booth
Fierce Pharma
Collegium Pharmaceutical
opioids
Xtampza ER
OPDP
Flag link:
Not over till it’s over: Pharma ad police issue another warning, this time to Amherst and Magna
Not over till it’s over: Pharma ad police issue another warning, this time to Amherst and Magna
Fierce Pharma
drug ads
FDA
OPDP
Zolpimist
Amherst Pharmaceuticals
Magna Pharmaceuticals
Flag link:
With only 2 warnings in 2017, pharma's ad police hits historic low
With only 2 warnings in 2017, pharma's ad police hits historic low
Fierce Pharma
warnings
drug ads
FDA
OPDP
Flag link:
OPDP Study Raises Questions About the Balance of Information in Mobile Ads OPDP Study Raises Questions About the Balance of Information in Mobile Ads
OPDP Study Raises Questions About the Balance of Information in Mobile Ads OPDP Study Raises Questions About the Balance of Information in Mobile Ads
RAPS.org
OPDP
mobile ads
drug ads
Flag link:
FDA slaps Pfizer's Hospira unit for 'misleading' YouTube ad
FDA slaps Pfizer's Hospira unit for 'misleading' YouTube ad
Fierce Pharma
FDA
Pfizer
OPDP
Hospira
YouTube
drug ads
Flag link:
FDA sends fewer drug promotion action letters in 2015--but is that a good thing for pharma?
FDA sends fewer drug promotion action letters in 2015--but is that a good thing for pharma?
Fierce Pharma Marketing
FDA
OPDP
digital media
Flag link:
Want to get a warning letter from OPDP? Omit drug risks from your promos
Want to get a warning letter from OPDP? Omit drug risks from your promos
Fierce Pharma Marketing
OPDP
warnings
risk factors
drug ads
JNJ
Flag link:
FDA's marketing police wrote only 10 tickets in 2014
FDA's marketing police wrote only 10 tickets in 2014
Fierce Pharma Marketing
FDA
drug marketing
OPDP
Flag link: